Notably, the downregulation of DAPK1 by RNAi reduced the apoptotic response to topotecan in cervical cancer cell lines and in primary cervical cancer samples, indicating that DAPK contributes to cell death signaling under topotecan treatment. This evidence concerns the gene DAPK1 and cervical cancer.